5 Must-Read Analyst Questions From CBIZ's Q2 Earnings Call

CBIZ’s second quarter results were met with a significant negative market reaction, as revenue growth lagged Wall Street’s expectations despite a substantial year-on-year increase. Management highlighted persistent headwinds in discretionary, project-based services, which clients are delaying amid economic uncertainty. CEO Jerry Grisko described the quarter’s environment as “anything but stable and certain,” attributing the softness to client caution on nonessential spending and increased pushback on pricing, particularly in areas most sensitive to macroeconomic conditions.

Is now the time to buy CBZ? Find out in our full research report (it’s free).

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From CBIZ’s Q2 Earnings Call

• Andrew Nicholas (William Blair) pressed for clarity on the outlook for advisory and project-based businesses, asking whether guidance assumed no improvement in discretionary demand. CEO Jerry Grisko confirmed guidance reflects ongoing caution and a flat outlook for the remainder of the year.
• Nicholas also questioned the sustainability of lower rate increases and whether this marks a structural shift. Grisko responded, “I don’t think we’ve reached the limits of what we’re going to be able to do in pricing,” and attributed the softness to broader market conditions.
• Nicholas further asked about the timing and magnitude of Marcum integration synergies. CFO Brad Lakhia indicated confidence in exceeding the $25 million synergy target and said these benefits are materializing sooner than previously expected.
• Christopher Moore (CJS Securities) requested more detail on integration costs and the outlook for future expenses. Lakhia explained that integration costs are primarily people- and advisor-related, with similar levels expected next year as the process continues.
• Marc Riddick (Sidoti) inquired about client feedback on the Marcum transaction and whether any operational friction had emerged. Grisko reported an overall positive transition, with some initial process friction quickly addressed through restructuring and team collaboration.

Catalysts in Upcoming Quarters

In the coming quarters, our analysts will be closely watching (1) the pace and effectiveness of Marcum integration and realization of targeted cost synergies, (2) whether pricing discipline can improve in an environment of client cost sensitivity, and (3) any signs of recovery in project-based and SEC-related revenue streams. Execution on cross-selling initiatives and progress on deleveraging will also be important to monitor.

CBIZ currently trades at $62.91, down from $76.22 just before the earnings. At this price, is it a buy or sell? Find out in our full research report (it’s free).

High-Quality Stocks for All Market Conditions

Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.

The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.